AU6503096A - Pyridine compounds, intermediates, processes, compositions, and methods - Google Patents

Pyridine compounds, intermediates, processes, compositions, and methods

Info

Publication number
AU6503096A
AU6503096A AU65030/96A AU6503096A AU6503096A AU 6503096 A AU6503096 A AU 6503096A AU 65030/96 A AU65030/96 A AU 65030/96A AU 6503096 A AU6503096 A AU 6503096A AU 6503096 A AU6503096 A AU 6503096A
Authority
AU
Australia
Prior art keywords
intermediates
compositions
processes
methods
pyridine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65030/96A
Inventor
Henry U Bryant
Don R. Finley
Ken Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU6503096A publication Critical patent/AU6503096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65030/96A 1995-07-27 1996-07-18 Pyridine compounds, intermediates, processes, compositions, and methods Abandoned AU6503096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US158895P 1995-07-27 1995-07-27
US001588 1995-07-27
PCT/US1996/011958 WO1997004778A1 (en) 1995-07-27 1996-07-18 Pyridine compounds, intermediates, processes, compositions, and methods

Publications (1)

Publication Number Publication Date
AU6503096A true AU6503096A (en) 1997-02-26

Family

ID=21696833

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65030/96A Abandoned AU6503096A (en) 1995-07-27 1996-07-18 Pyridine compounds, intermediates, processes, compositions, and methods

Country Status (4)

Country Link
JP (1) JPH11510163A (en)
AU (1) AU6503096A (en)
CA (1) CA2227877A1 (en)
WO (1) WO1997004778A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174901B1 (en) * 1998-12-18 2001-01-16 Amgen Inc. Substituted pyridine and pyridazine compounds and methods of use
KR20040019088A (en) 2001-08-03 2004-03-04 이시하라 산교 가부시끼가이샤 Process for Preparation of 2-Phenylacetophenone Derivatives and Precursors Therefor
JP2005531520A (en) 2002-03-28 2005-10-20 メルク　エンド　カムパニー　インコーポレーテッド Substituted 2,3-diphenylpyridines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535330A (en) * 1968-04-29 1970-10-20 Sandoz Ag 2,6-diphenyl - 4 - (p-(dilower-alkyl amino lower - alkoxy)phenyl)pyridines and derivatives thereof
US3535329A (en) * 1969-03-07 1970-10-20 Sandoz Ag Certain 2-(4-(dilower alkylaminoloweralkoxy)phenyl)-4,6-diphenyl pyridines and derivatives thereof

Also Published As

Publication number Publication date
JPH11510163A (en) 1999-09-07
CA2227877A1 (en) 1997-02-13
WO1997004778A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
AU694837B2 (en) Naphthyl compounds, intermediates, compositions, and methods
AU6374896A (en) Cable-sheathing composition
HU9600448D0 (en) Naphthyl compounds, intermediates, and compositions, containing them
AU1504599A (en) Novel pyridine compounds
AUPN453895A0 (en) Spray method
AU2844897A (en) Bicyclic-fused pyridines
AU5060796A (en) Composition
AU6584596A (en) Novel hydroxypyridinones
AU3264695A (en) Pyridine derivative
AU6515696A (en) Selective herbicidal composition
AU1140197A (en) Pyridyl carbamates, process and intermediates for the preparation and use thereof
AU5798996A (en) Adnaz, compositions and processes
AU4437096A (en) Substituted 2-phenylpyridines as herbicides
AU7570296A (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
AU4436696A (en) Substituted 2-phenylpyridines as herbicides
AU695845B2 (en) Pyridine derivative
AU4483596A (en) Substituted 2-phenylpyridines as herbicides
AU6503096A (en) Pyridine compounds, intermediates, processes, compositions, and methods
GB9615378D0 (en) Benzene compounds, intermediates, processes, compositions, and methods
AU2753195A (en) Pyridine derivative
AU7537596A (en) Improved nogging for building purposes
AU7702996A (en) Solid composition
AU1118797A (en) Process
AU5271296A (en) Novel method
AU6659096A (en) Substituted 2-phenylpyridines useful as herbicides